Category: Regulations

regulations

Feb 02
Agreed settlement with Curalia OVV

This press release is not available in English. Please consult the French or Dutch site. Source: FSMA

Feb 02
Information Notice 2/1/22

Notice Comments Summary FINRA Rule 4111 (Restricted Firm Obligations) became effective on January 1, 2022. This Notice announces that the first “Evaluation Date” for Rule 4111 will be June 1, 2022.   Questions concerning this Notice should be directed to: Kosha Dalal, Vice President and Associate General Counsel, Office of General Counsel (OGC), at (202) […]

Feb 02
The CFTC and 27 State Securities Regulatory Agencies Charge Los Angeles Area Precious Metals Dealer in Ongoing $68 Million Fraud Targeting the Elderly

Washington, D.C. — The Commodity Futures Trading Commission and 27 state securities regulatory agencies that are members of the North American Securities Administrators Association (NASAA) announced the filing of a joint civil enforcement action in the U.S. District Court for the Central District of California against a precious metals dealer and its owner for orchestrating […]

Feb 02
Approval of the modified market rules of Alternext Brussels (commercial name: Euronext Growth)

The Financial Services and Markets Authority (FSMA) hereby announces that on 7 July 2020, in accordance with Article 2 of the Royal Decree of 21 August 2008 on the rules for certain multilateral trading facilities, it approved the modified market rules of Alternext Brussels (Euronext Growth). These market rules enter into force as of 17 August […]

Feb 02
Press release on the reopening of trading in Acacia Pharma

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Acacia Pharma, ISIN GB00BYWF9Y76, on Euronext Brussels will re-open on 14-08-2020 at 9:00 CET. Source: FSMA

Feb 02
Press release on the suspension of trading in Acacia Pharma

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Acacia Pharma, ISIN GB00BYWF9Y76, on Euronext Brussels is suspended on the request of the company from 13/08/2020 at 14:45 CET until the publication of a press release.   […]

Feb 02
Guidelines on stress test scenarios under the Money Market Funds Regulation

This Communication (FSMA_2020_09; available in French or Dutch only; annex available in English) addresses the guidelines drawn up by the European Securities and Markets Authority (ESMA) regarding the stress test scenarios based on the EU’s Money Market Funds Regulation, and on the implementation of those guidelines by the FSMA. Source: FSMA

Feb 02
UCM Limited (www.ucm-limited.com) – cloned firm

The Financial Services and Markets Authority (FSMA) warns the public against the activities of the website named www.ucm-limited.com, which offers investment services without complying with Belgian financial legislation. This ‘company’ is not authorized to provide investment services in or from Belgium. Moreover, the offer made via that website shows numerous indications of fraud and seems to be similar to […]

Feb 02
Fraudulent wealth management offers: Stay vigilant!

In the past few weeks, the FSMA has received new complaints from consumers who have been approached by companies offering wealth management and/or savings plans, most often with a guaranteed return. The FSMA warns consumers against these tempting offers, because often behind them are fraudsters who are not authorized to make such offers, the sole […]

Feb 02
Agreed settlement with Bank Degroof Petercam NV/SA

This press release is not available in English. Please consult the French or Dutch page. Source: FSMA